GARADACIMAB
UNII 32W6AJL0DY

Substance Identification & Data

This profile provides standardized clinical and technical data for Garadacimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 32W6AJL0DY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2162134-62-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

32W6AJL0DY

CAS Registry Number

2162134-62-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GARADACIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

32W6AJL0DY

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C166633

National Cancer Institute reference terminology for clinical and research data.

INN ID

10996

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Garadacimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GARADACIMAB

GARADACIMAB-GXII

Common Names & Synonyms

CSL-312

CSL312 (ANTI-FXIIA MONOCLONAL ANTIBODY)

GARADACIMAB [INN]

GARADACIMAB [WHO-DD]

IMMUNOGLOBULIN G4, ANTI-(HUMAN BLOOD-COAGULATION FACTOR XIIA) (HUMAN MONOCLONAL CSL312 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CSL312 .LAMBDA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-LAMBDA, ANTI-(HOMO SAPIENS F12 (COAGULATION FACTOR XII, HAGEMAN FACTOR) ACTIVATED (F12A, FXIIA)), MONOCLONAL ANTIBODY